|
| ID |
DDInter669 |
| Drug Type |
small molecule |
| Molecular Formula |
C22H25Clo7 |
| Molecular Weight |
436.888
|
| Description |
Ertugliflozin is a SGLT2 inhibitor used to treat type 2 diabetes mellitus.
|
| ATC Classification |
A10BD23
A10BK04
A10BD24
|
| IUPAC Name |
(1S,2S,3S,4R,5S)-5-{4-Chloro-3-[(4-Ethoxyphenyl)Methyl]Phenyl}-1-(Hydroxymethyl)-6,8-Dioxabicyclo[3.2.1]Octane-2,3,4-Triol |
| InChI |
Inchi=1S/C22H25Clo7/C1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/H3-8,10,18-20,24-27H,2,9,11-12H2,1H3/T18-,19-,20+,21-,22-/M0/S1 |
| InChI Key |
MCIACXAZCBVDEE-CUUWFGFTSA-N |
| Canonical SMILES |
CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|